NOVEL CRISPR ENZYMES AND SYSTEMS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240182928A1
SERIAL NO

18235760

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides for systems, methods, and compositions for targeting nucleic acids. In particular, the invention provides non-naturally occurring or engineered RNA-targeting systems comprising a novel RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component like a guide RNA.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES6011 EXECUTIVE BLVD STE 325 MSC 7660 NIH/OD/OIR/OTT BETHESDA MD 20892-7660

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abudayyeh, Omar O Cambridge, US 33 957
Gootenberg, Jonathan S Cambridge, US 26 302
Joung, Julia Cambridge, US 17 130
Konermann, Silvana Cambridge, US 41 828
Koonin, Eugene Bethesda, US 12 144
Lander, Eric S Cambridge, US 79 1197
Makarova, Kira S Bethesda, US 11 166
Minakhin, Leonid New Brunswick, US 10 127
Semenova, Ekaterina New Brunswick, US 11 128
Severinov, Konstantin New Brunswick, US 18 179
Shmakov, Sergey Moscow, RU 11 166
Wolf, Yuri I Bethesda, US 11 166
Zhang, Feng Cambridge, US 1002 28040

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation